Trial Profile
A Clinical Safety and Efficacy Evaluation of Zylet (Loteprednol Etabonate and Tobramycin Ophthalmic Suspension, 0.5%/0.3% vs. Tobradex (Tobramycin and Dexamethasone Ophthalmic Suspension, 0.3%/0.1%) in the Treatment of Blepharokeratoconjunctivitis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2013
Price :
$35
*
At a glance
- Drugs Loteprednol etabonate/tobramycin (Primary) ; Tobramycin/dexamethasone
- Indications Bacterial infections; Blepharoconjunctivitis; Keratoconjunctivitis; Ocular inflammation
- Focus Therapeutic Use
- Sponsors Bausch & Lomb
- 27 May 2009 New trial record